Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Breast Pap Test Trial"

16:46 EDT 18th April 2014 | BioPortfolio

Original Source: NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versu...

Matching Channels

Schilling test

Sniff test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

New Genetic Test for Breast Cancer Launched

A cutting-edge test that identifies mutations in breast cancer genes that are associated with increased risk of inherited breast and...

Genetic breast cancer screening may benefit those at intermediate risk

Archimedes Inc., a healthcare modeling and analytics company, has announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for bre...

Published study validates MammaPrint test for long-term prediction of breast cancer outcome

A newly published study concludes that the MammaPrint® breast cancer test can accurately stratify a woman's breast cancer risk for up to 25 years after she is first diagnosed with the disease. U.S...

Computer model suggests genetic breast cancer screening may benefit those at intermediate risk

(GCI Health) Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genet...

Sequential Breast Regimen Passes Clinical Test (CME/CE)

(MedPage Today) -- A potentially more heart-friendly sequential chemotherapy regimen for breast cancer proved as effective as the standard concurrent approach, a randomized trial showed.

Foundation for NIH announces first results of I-SPY 2 breast cancer clinical trial

The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium a...

Blood Test Aims to Predict Breast Cancer's Return

TUESDAY, April 15, 2014 -- A new blood test may one day help predict the recurrence of breast cancer and also a woman's response to breast cancer treatment, researchers report. "We are able to do this...

Researchers test promising new breast cancer drugs

The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Sy...

Matching PubMed Articles

Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer.

We investigated the efficacy and toxicity of sorafenib, a multikinase inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in combination with vinorelbine therapy in a phase I/II...

Positive Results for Drug Combo in I-SPY 2 Trial.

In results from one part of the I-SPY 2 trial announced at the 2013 San Antonio Breast Cancer Symposium, neoadjuvant veliparib plus carboplatin improved outcomes for women with triple-negative breast...

Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study.

Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limit...

Prospective Cohort Study: Whether or Not Patients Benefit from Participation Itself in Randomized-controlled Trials (SELECT BC ECO).

The randomized-controlled trial is widely accepted as a clinical trial to decide a standard therapy. It remains to be concluded whether or not patients benefit from participation itself in a randomize...

Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial.

There is a lack of trials of psychodynamic treatments of depression in breast cancer patients. The purpose of this trial was to determine the efficacy of short-term psychodynamic psychotherapy (STPP)...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement